GlassScriptPhysician profile
Christopher T Dao
NPI 1366103764
$6,258.66
in general payments reported to CMS, 2019-2025
52 companies · $2,160 in 2025
The $2,160 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,601 · 2024: $2,497 · 2025: $2,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,234 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,233.66 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $778.61 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $619.07 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $575.15 | 2023-2025 | |
| Pfizer INC. | $568.69 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $533.56 | 2023-2025 | Farxiga, Airsupra, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $310.44 | 2023-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $269.85 | 2023-2025 | Jardiance |
| Amgen INC. | $237.24 | 2023-2025 | Evenity, Prolia, Repatha |
| Otsuka America Pharmaceutical, INC. | $204.62 | 2023-2025 | Rexulti |
| Shield Therapeutics INC | $185.17 | 2023-2025 | Accrufer |
| Glaxosmithkline, LLC. | $172.37 | 2023-2025 | Trelegy Ellipta |
| Abbott Laboratories | $137.54 | 2024-2025 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $129.95 | 2024-2025 | Ajovy |
| Gilead Sciences, INC. | $127.91 | 2024 | |
| Dexcom, INC. | $96.72 | 2023-2025 | Dexcom G6 Transmitter |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $94.64 | 2023-2024 | Heplisav-B |
| Ardelyx, INC. | $87.06 | 2024-2025 | Ibsrela |
| Idorsia Pharmaceuticals US INC | $86.12 | 2023-2024 | Tryvio, Quviviq |
| Merck Sharp & Dohme LLC | $73.76 | 2023-2025 | Gardasil 9, Capvaxive, Gardasil |
| Xeris Pharmaceuticals, INC. | $63.75 | 2025 | Gvoke Hypopen, Recorlev |
| Takeda Pharmaceuticals U.S.A., INC. | $59.90 | 2023-2025 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $59.86 | 2024-2025 | Caplyta |
| Lundbeck LLC | $58.56 | 2023-2024 | Rexulti |
| Corium, LLC | $52.29 | 2023 | Azstarys |
| Exact Sciences Corporation | $48.79 | 2025 | Cologuard Collection Kit |
| Genentech USA, INC. | $46.33 | 2024 | Xolair |
| Antares Pharma, INC. | $45.78 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Novartis Pharmaceuticals Corporation | $37.84 | 2023-2024 | |
| Axsome Therapeutics, INC. | $31.62 | 2024-2025 | Sunosi |
| Watermark Medical, INC. | $30.42 | 2024 | |
| Janssen Pharmaceuticals, INC | $30.29 | 2023-2024 | Xarelto |
| Phathom Pharmaceuticals, INC. | $30.24 | 2024-2025 | Voquezna |
| Mylan Specialty L.P. | $25.26 | 2023 | Yupelri |
| Pacira Pharmaceuticals Incorporated | $25.02 | 2023 | Zilretta |
| Currax Pharmaceuticals LLC | $25.00 | 2023 | Nexletol |
| Ars Pharmaceuticals Operations, INC. | $22.92 | 2025 | Neffy |
| Regeneron Healthcare Solutions, INC. | $22.88 | 2024 | Dupixent |
| Biogen, INC. | $22.80 | 2024 | Leqembi |
| Boston Scientific Corporation | $22.22 | 2023 | Wavewriter Alpha Prime 16 |
| Esperion Therapeutics, INC. | $20.90 | 2025 | Nexletol |
| Vertex Pharmaceuticals Incorporated | $20.60 | 2025 | |
| Philips North America LLC | $18.61 | 2024 | (Ck6) Holter |
| Tolmar, INC. | $18.24 | 2025 | Jatenzo |
| Endo Pharmaceuticals INC. | $16.88 | 2023 | Xiaflex, Aveed |
| Abiomed | $16.18 | 2024 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $15.90 | 2023 | |
| Edwards Lifesciences Corporation | $15.00 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amneal Pharmaceuticals LLC | $14.81 | 2024 | Unithroid |
| Baxter Healthcare | $14.75 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Viatris Specialty LLC | $14.46 | 2025 | Yupelri |
| Astellas Pharma US INC | $13.94 | 2024 | Veozah |
| Tms Neurohealth Centers INC. | $8.15 | 2025 | Tms Neurohealth Centers INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Dao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.